Sedation is an important aspect of care for critically ill newborns. Proper sedation reduces
stress during procedures such as mechanical ventilation. Midazolam, a short‐acting …

A 32-day-old girl who was born at 32 weeks' gestation was transferred to our neonatal
intensive care unit to perform laser photocoagulation for the treatment of retinopathy of …

Background. This study was conducted to investigate the incidence of, and factors
associated with, myoclonus‐like abnormal movements of Japanese infants following …

Objective: To determine the safety and efficacy of flumazenil when given for reversal of
benzodiazepine-induced conscious sedation in children. Design: Multicenter study …

Midazolam is a drug belonging to the benzodiazepine group and is used commonly for
seizure control as well as preoperative and procedure-related sedation in neonates. Many …

Midazolam can induce acute dystonia in childhood. We report the development of acute
dystonia in a 6-year-old girl after receiving midazolam as a sedative. Dystonic contractions …

Midazolam is a short-acting benzodiazepine used in neonatal intensive care units for
sedation. Reports from Europe have described adverse neurological effects in infants …

Midazolam is a water soluble benzodiazepine, with a short elimination half-life in adults and
children. An IV bolus (0.2 mg· kg− 1) immediately followed by continuous infusion of 0.06 …

Midazolam is a water soluble benzodiazepine, with a short elimination half-life in adults and
children. An IV bolus of midazolam 0.2 mg· kg− 1 was administered to 10 critically ill …

Midazolam is a benzodiazepine with rapid onset of action and short duration of effect. In
healthy neonates the half‐life (t1/2) and the clearance (Cl) are 3.3‐fold longer and 3.7‐fold …